Goldman Sachs’s Streamline Health Solutions STRM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-2,520
Closed -$59K 5699
2020
Q3
$59K Buy
+2,520
New +$52.7K ﹤0.01% 5164
2020
Q2
Sell
-2,139
Closed -$27K 5467
2020
Q1
$27K Buy
2,139
+3
+0.1% +$52 ﹤0.01% 5106
2019
Q4
$45K Buy
+2,136
New +$39.4K ﹤0.01% 5118
2018
Q1
Sell
-773
Closed -$20K 6378
2017
Q4
$20K Buy
+773
New +$17.7K ﹤0.01% 6116
2017
Q1
Sell
-1,972
Closed -$37K 6994
2016
Q4
$37K Buy
1,972
+635
+47% +$15.9K ﹤0.01% 6467
2016
Q3
$37K Sell
1,337
-1,546
-54% -$34.8K ﹤0.01% 6572
2016
Q2
$52K Buy
+2,883
New +$55.9K ﹤0.01% 6411

Other funds holding STRM

Goldman Sachs's STRM Position: Q4 2020 in Review

Goldman Sachs sold out of Streamline Health Solutions (STRM) in Q4 2020, closing a stake of 2,520 shares — an estimated $59K sold.

Goldman Sachs first reported a position in STRM in Q2 2016 and held it in 7 quarters. The position peaked at $59K in Q3 2020. 33 funds tracked by Wall St. Rank hold STRM as of Q4 2020.

  • Goldman Sachs reported no remaining Streamline Health Solutions position as of Q4 2020 after selling out during the quarter.
  • Goldman Sachs sold 2,520 Streamline Health Solutions shares in Q4 2020, an estimated $59K.
  • Goldman Sachs first reported a position in Streamline Health Solutions in Q2 2016 and held it in 7 quarters.
  • Goldman Sachs's Streamline Health Solutions position peaked at $59K in Q3 2020.
  • 33 funds tracked by Wall St. Rank held Streamline Health Solutions as of Q4 2020.

Based on Goldman Sachs's 13F filing for Q4 2020, filed 12 Feb 2021.